Trial Profile
A Multicentre, Prospective, Non-Interventional Study to Assess the Intra-patient Variability of Tacrolimus Once and Twice Daily After Kidney Transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Oct 2022
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- Acronyms Pelicon
- 11 Sep 2018 Status changed from recruiting to completed.
- 04 Sep 2013 New trial record